SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 45 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $402,000 | -20.6% | 28,800 | -22.0% | 0.01% | -22.2% |
| Q1 2017 | $506,000 | +90.9% | 36,900 | 0.0% | 0.01% | +80.0% |
| Q4 2016 | $265,000 | -52.6% | 36,900 | 0.0% | 0.01% | -50.0% |
| Q3 2016 | $559,000 | +24.8% | 36,900 | -18.9% | 0.01% | +25.0% |
| Q2 2016 | $448,000 | -15.9% | 45,500 | +13.8% | 0.01% | -11.1% |
| Q1 2016 | $533,000 | – | 40,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 8,076 | $174,522 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 46 | $994 | 0.00% |